Study Notes on Cancer Cell Metabolism and Reactive Oxygen Species (ROS)

Overview of Cancer Cells' Metabolism and Reactive Oxygen Species (ROS)

Authors and Affiliation

  • Zahra Ghanbari Movaheda
  • Mohsen Rastegari-Pouyanib
  • Mohammad Hossein Mohammadi
  • Kamran Mansouri
    • Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
    • Department of Immunology, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Abstract

  • Cancer cells adapt their metabolism to counteract high levels of ROS and low energy sources, impacting cell fate and drug resistance.
  • Cancer cells typically show increased glycolysis.
  • Cancer stem cells (CSCs) rely more on the pentose phosphate pathway (PPP).
  • During oxidative stress, it is proposed that cancer cells shift from glycolysis to PPP, indicating a potential transition toward a CSC-like state, which can inform targeted cancer therapies.

Keywords

  • Cancer cell
  • Cancer stem cell
  • Glycolysis
  • ROS (Reactive Oxygen Species)
  • Pentose phosphate pathway (PPP)

Summary of Key Findings

  1. Cancer Cells and ROS

    • High levels of ROS are a result of genetic and metabolic alterations as well as microenvironment factors.
    • Sources of ROS include increased metabolic activity, mitochondrial dysfunction, and certain enzymatic activities (e.g., oxidases and cyclooxygenases).
    • Cancer cells produce more hydrogen peroxide (H2O2) and superoxide (O2−∙O_2^{-\bullet}) than normal cells.
    • Conditions such as hypoxia and inflammation further increase ROS levels.
    • Cancer cells have a higher antioxidant capacity, providing a survival advantage under oxidative stress.

  2. Cellular Metabolism and Redox Homeostasis

    • The link between cellular metabolism and redox homeostasis allows cancer cells to manage oxidative damage.
    • Increased glycolysis (the Warburg effect) and PPP can help mitigate ROS production.
    • The Warburg effect refers to the preference of cancer cells to convert glucose to lactate for energy even in the presence of oxygen.
    • Studies have shown that activating glycolysis and PPP can reduce oxidative stress markers like O2−∙O_2^{-\bullet} and H2O2.

  3. Role of Cancer Stem Cells (CSCs)

    • CSCs are a small subset of cancer cells with self-renewal capability crucial for tumor growth and recurrence.
    • They show enhanced metabolism through the PPP compared to differentiated cancer cells.
    • Exposure to oxidative stress results in increased PPP activity, suggesting a metabolic switch that supports CSC survival and drug resistance.

  4. Metabolic Pathways Influenced by ROS

    • Glycolysis: This pathway generates energy and serves as a precursor for biomass, helping cancer cells adapt to low oxygen conditions.
      • Anaerobic glycolysis produces two ATP molecules per glucose while aerobic processes yield about seven ATPs.
    • Darwinian Warburg Effect: Cancer cells increase glycolysis even with available oxygen, due to their altered energy demands.
      • Provides substrates for nucleotide synthesis and helps reduce overall ROS production.
    • Pentose Phosphate Pathway (PPP): Generates NADPH for antioxidant defense and is implicated in cellular growth and repair.

  5. Transitioning from Glycolysis to the PPP

    • Under persistent oxidative stress, an initial increase in glycolysis is followed by a shift towards PPP.
    • Factors affecting this transition include:
      • HIF-1 (Hypoxia-Inducible Factor): Upregulates glycolytic and transport pathways in response to low oxygen.
      • PKM2 (Pyruvate Kinase M2): Regulates glucose flux and can direct metabolites towards PPP.
      • GAPDH (Glyceraldehyde-3-phosphate Dehydrogenase): Inactivation by ROS favors switch to PPP.
      • TIGAR (TP53-Induced Glycolysis and Apoptosis Regulator): Inhibits glycolysis and supports PPP under oxidative stress.

  6. CSCs and Resistance to Therapy

    • CSCs exhibit an enhanced PPP which contributes to drug resistance.
    • They maintain high levels of reducing capacity to counter oxidative stress, promoting survival after therapy.
    • Treatment strategies may need to factor in the role of PPP activity in CSCs to improve efficacy.

  7. Clinical Implications and Future Directions

    • Understanding ROS dynamics and metabolic shifts in cancer cells could offer strategies for enhancing therapeutic effectiveness.
    • Targeting key regulatory pathways in metabolism, including G6PD in the PPP, shows promise for improving outcomes in cancer therapy.

  8. Conclusion

    • The balance between glycolysis and PPP is central to the survival and proliferation of cancer cells under oxidative stress.
    • Maladaptive responses to ROS can induce transitions toward CSC characters, suggesting the need for targeted therapies that address these metabolic pathways effectively.

References

  • Comprehensive reference list providing the supporting literature and previous findings related to ROS, cancer metabolism, and stem cell biology.